NGM282 inhibited bile acid synthesis and decreased fibrosis markers without significantly affecting alkaline phosphatase levels among patients with primary sclerosing cholangitis, according to data published in Journal of Hepatology.
“Primary sclerosing cholangitis (PSC) is a chronic liver disease characterized by strictures of the biliary tree for which there is presently a dearth of effective medical treatment,” Gideon M. Hirschfield, MD, PhD, from the Birmingham Biomedical Research Center in the United Kingdom, and colleagues wrote. “The current trial confirms the clinical

Source link